# Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide

> **NCT07173738** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 44 (actual)

## Conditions studied

- Pulmonary Arterial Hypertension

## Interventions

- **DRUG:** BIA 5-1058
- **DRUG:** Furosemide
- **DRUG:** BIA 5-1058 and Furosemide

## Key facts

- **NCT ID:** NCT07173738
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-11
- **Primary completion:** 2018-09-07
- **Final completion:** 2018-09-07
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07173738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07173738, "Pharmacokinetics, Safety and Tolerability of Concurrent Doses of BIA 5-1058 and Furosemide". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT07173738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*